ripekg:evaluation/RIPEAE59AF25CB9D16527 |
prov:used |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE59AF25CB9D16527 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE59AF25CB9D16527 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:concerns |
ripekg:work/10.1111%2Fpai.12978EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:recruitmentEndDateExtractionRationale |
No explicit end-of-recruitment date after full search. |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:recruitmentStartDate |
11-2017 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:recruitmentStartDateExtractionRationale |
Study was conducted from November to December 2017; used start of conducted range as recruitment_start per rule 5; no specific FPI elsewhere. |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:studyEndDate |
12-2017 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
ripe:studyEndDateExtractionRationale |
Study was conducted from November to December 2017; used end of conducted range as study_end_date per rule 5; no specific completion date. |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-human-2-2 |
ripekg:study-design-evidence/RIPEAE59AF25CB9D16527 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-2-2 |